Musculoskeletal safety outcomes of patients receiving daptomycin with HMG-CoA reductase inhibitors.
about
Musculoskeletal safety outcomes of patients receiving daptomycin with HMG-CoA reductase inhibitors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@ast
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@en
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@nl
type
label
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@ast
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@en
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@nl
prefLabel
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@ast
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@en
Musculoskeletal safety outcome ...... HMG-CoA reductase inhibitors.
@nl
P2093
P2860
P356
P1476
Musculoskeletal safety outcome ...... h HMG-CoA reductase inhibitors
@en
P2093
Brianne L Dunn
Kathey Fulton Rumley
P Brandon Bookstaver
Southeastern Research Group Endeavor (SERGE-45)
Z Kevin Lu
P2860
P304
P356
10.1128/AAC.02910-14
P407
P577
2014-07-14T00:00:00Z